HomeCHRS • NASDAQ
add
Coherus Oncology Inc
Previous close
$1.69
Day range
$1.61 - $1.76
Year range
$0.71 - $2.62
Market cap
244.32M USD
Avg Volume
1.90M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 12.75M | 64.85% |
Operating expense | 51.98M | 3.21% |
Net income | -37.64M | 25.75% |
Net profit margin | -295.29 | 54.96% |
Earnings per share | -0.34 | -21.43% |
EBITDA | -42.38M | 4.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 172.12M | 36.62% |
Total assets | 258.34M | -42.40% |
Total liabilities | 197.33M | -66.01% |
Total equity | 61.01M | — |
Shares outstanding | 149.89M | — |
Price to book | 3.38 | — |
Return on assets | -27.93% | — |
Return on capital | -84.05% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -37.64M | 25.75% |
Cash from operations | -19.72M | -168.92% |
Cash from investing | -2.84M | -423.62% |
Cash from financing | 8.08M | 3,398.27% |
Net change in cash | -14.47M | -151.15% |
Free cash flow | -22.01M | -201.90% |
About
Founded
2010
Headquarters
Website
Employees
147
